Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2013-03-21Clinical Trial Update: Two Pieces of Fruit to Type 2 Diabetics? [NA]
Clinical trial testing whether consuming two pieces of fruit affects outcomes in Type 2 diabetes mellitus has been terminated.
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Intensive Life-Style Intervention in Type 2 Diabetes Patients [NA]
A completed clinical trial evaluating intensive lifestyle intervention in adults with Type 2 diabetes mellitus.
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Problem Solving and Cardiovascular Disease Risk Management in Diabetic Blacks [NA]
A completed Johns Hopkins University clinical trial explored problem-solving approaches and cardiovascular disease risk management in Black …
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Genetic Markers of Coronary Heart Disease in Type 2 Diabetes
This completed clinical trial evaluated genetic markers associated with coronary heart disease in individuals with Type 2 diabetes.
-
CLINICAL_TRIALS trial_result · 2013-03-20Clinical Trial Update: Treatment Use of Generex Oral-lyn™ in Patients With Diabetes
Clinical trial NCT00948493 evaluating Generex Oral-lyn for diabetes is no longer available.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-03-15Clinical Trial Update: Comparison of Two Treatment Regimens (Sitagliptin Versus Liraglutide) on Participants Who Failed to Achieve Good Glucose Control on Metformin Alone (MK-0431-403) [Phase 3]
Phase 3 trial comparing sitagliptin versus liraglutide as add-on therapy for type 2 diabetes patients not adequately controlled on metformin…
-
FDA approval · 2013-03-14FDA Approved: CYCLOSET — Supplemental Application (Avvisto Therapeutics LLC)
FDA approved a supplemental application for CYCLOSET (bromocriptine mesylate) from Avvisto Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2013-03-14Clinical Trial Update: Exenatide Versus Glimepiride in Patients With Type 2 Diabetes [Phase 3]
A Phase 3 head-to-head trial comparing exenatide with glimepiride in adults with type 2 diabetes has completed, with results posted in March…
-
FDA approval · 2013-03-14FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for insulin lispro from Eli Lilly and Company. The notice indicates a supplemental approval rela…
-
CLINICAL_TRIALS trial_result · 2013-03-13Clinical Trial Update: Testing the Effect of the InsuPad Device in Daily Life Conditions [NA]
The clinical trial evaluating the InsuPad device in daily life conditions for adults with Type 1 diabetes mellitus and Type 2 diabetes melli…
-
FDA approval · 2013-03-11FDA Approved: HUMALOG MIX75/25 — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for HUMALOG MIX75/25, a premixed insulin lispro product manufactured by Eli Lilly and Company.
-
FDA approval · 2013-03-11FDA Approved: HUMALOG MIX50/50 KWIKPEN — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMALOG MIX50/50 KWIKPEN (insulin lispro) from Eli Lilly and Company.
-
FDA approval · 2013-03-11FDA Approved: INSULIN LISPRO — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for insulin lispro (Humalog) submitted by Eli Lilly and Company. The approval confirms the supplemen…
-
CLINICAL_TRIALS trial_result · 2013-03-11Clinical Trial Update: Severe Insulin Resistance in Patients With Type 2 Diabetes [NA]
This ClinicalTrials.gov update notes that the study on severe insulin resistance in patients with Type 2 Diabetes Mellitus has completed.
-
FDA approval · 2013-03-09FDA Approved: INSULIN ASPART PROTAMINE AND INSULIN ASPART MIX 70/30 — Supplemental Application (Novo Nordisk Pharma, Inc.)
The FDA approved a supplemental application for the insulin aspart protamine and insulin aspart mix 70/30 product, confirming continued regu…
-
FDA approval · 2013-03-09FDA Approved: NOVOLOG — Supplemental Application (Novo Nordisk)
FDA approves NovoLog (insulin aspart) supplemental application submitted by Novo Nordisk. The approval updates the labeling and/or indicatio…
-
FDA label_change · 2013-03-09FDA Approved: LEVEMIR — Supplemental Application (Novo Nordisk)
The FDA approved a Novo Nordisk supplemental application for LEVEMIR (insulin detemir), updating the product labeling.
-
FDA approval · 2013-03-09FDA Approved: HUMULIN 70/30 — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for HUMULIN 70/30 (insulin human) from Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: HUMULIN R — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin R (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: HUMULIN N — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Humulin N (insulin human) submitted by Eli Lilly and Company.
-
FDA approval · 2013-03-09FDA Approved: NOVOLIN N — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for NOVOLIN N (human insulin) from Novo Nordisk, adding regulatory clearance for the product. This a…
-
CLINICAL_TRIALS trial_result · 2013-03-08Clinical Trial Update: New Frontiers on Bariatric Surgical Procedures: Classical Bypass for Type-2 Diabetic Patients With Obesity Grade I [Phase 2, Phase 3]
A completed Phase 2/3 trial evaluating the classical bypass bariatric procedure in patients with type 2 diabetes and obesity grade I.
-
CLINICAL_TRIALS research · 2013-03-08Clinical Trial Update: Progression From Impaired Fasting Glucose to Type 2 Diabetes Mellitus Among Subjects With and Without Hypertension in Primary Care Setting
This completed clinical trial examined progression from impaired fasting glucose to Type 2 Diabetes Mellitus in adults, comparing outcomes f…
-
FDA approval · 2013-03-07FDA Approved: WELCHOL — Supplemental Application (Cosette Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Welchol (colesevelam hydrochloride) filed by Cosette Pharmaceuticals, Inc.
-
CLINICAL_TRIALS trial_result · 2013-03-07Clinical Trial Update: Restoration of Beta Cell Function and Cardiovascular Parameters in Relation to Adipoinsular and Enteroinsular Axes After Gastric Bypass Surgery [NA]
Clinical trial update on restoration of beta cell function and cardiovascular parameters after gastric bypass surgery in adults with Type 2 …